The intrinsic stiffness of human trabecular meshwork cells increases with senescence

Oncotarget

Volumn 6, Issue 17, 2015, Pages 15362-15374

  Morgan, Joshua T ^a   Raghunathan, Vijay Krishna ^a   Chang, Yow Ren ^a   Murphy, Christopher J ^a,b   Russell, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytoskeleton; Mechanobiology; Senescence; Trabecular meshwork

Indexed keywords

MEMBRANE PROTEIN; SFRP1 PROTEIN, HUMAN; SIGNAL PEPTIDE; VIMENTIN;

ATOMIC FORCE MICROSCOPY; BIOSYNTHESIS; CELL AGING; CELL CULTURE; CYTOLOGY; DISEASE COURSE; GLAUCOMA; HUMAN; MECHANICAL STRESS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STRESS FIBER; TRABECULAR MESHWORK;

CELL AGING; CELLS, CULTURED; DISEASE PROGRESSION; GLAUCOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICROSCOPY, ATOMIC FORCE; REAL-TIME POLYMERASE CHAIN REACTION; STRESS FIBERS; STRESS, MECHANICAL; TRABECULAR MESHWORK; VIMENTIN;

EID: 84934299760     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3798     Document Type: Article

References (149)

1. Quigley HA and Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262-267.
2. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993; 328:1097-1106.
3. Johnson M. 'What controls aqueous humour outflow resistance?'. Exp Eye Res. 2006; 82:545-557.
4. Johnstone MA and Grant WG. Pressure-dependent changes in structures of the aqueous outflow system of human and monkey eyes. Am J Ophthalmol. 1973; 75:365-383.
5. Maepea O and Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp Eye Res. 1992; 54:879-883.
6. Acott TS and Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008; 86(4):543-561.
7. Keller KE and Acott TS. The Juxtacanalicular Region of Ocular Trabecular Meshwork: A Tissue with a Unique Extracellular Matrix and Specialized Function. Journal of ocular biology. 2013; 1(1):3.
8. Bhatt K, Gong H and Freddo TF. Freeze-fracture studies of interendothelial junctions in the angle of the human eye. Invest Ophthalmol Vis Sci. 1995; 36:1379-1389.
9. Gong H, Ruberti J, Overby D, Johnson M and Freddo TF. A new view of the human trabecular meshwork using quick-freeze, deep-etch electron microscopy. Exp Eye Res. 2002; 75:347-358.
10. Grierson I, Lee WR, Abraham S and Howes RC. Associations between the cells of the walls of Schlemm's canal. Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie Albrecht von Graefe's archive for clinical and experimental ophthalmology. 1978; 208:33-47.
11. Inomata H, Bill A and Smelser GK. Aqueous humor pathways through the trabecular meshwork and into Schlemm's canal in the cynomolgus monkey (Macaca irus). An electron microscopic study. Am J Ophthalmol. 1972; 73:760-789.
12. Last JA, Pan T, Ding Y, Reilly CM, Keller K, Acott TS, Fautsch MP, Murphy CJ and Russell P. Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci. 2011; 52:2147-2152.
13. Hoare MJ, Grierson I, Brotchie D, Pollock N, Cracknell K and Clark AF. Cross-linked actin networks (CLANs) in the trabecular meshwork of the normal and glaucomatous human eye in situ. Invest Ophthalmol Vis Sci. 2009; 50:1255-1263.
14. Clark AF, Miggans ST, Wilson K, Browder S and McCartney MD. Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells. Journal of glaucoma. 1995; 4:183-188.
15. Fuchshofer R and Tamm ER. The role of TGF-beta in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 2012; 347:279-290.
16. Saika S. TGFbeta pathobiology in the eye. Lab Invest. 2006; 86:106-115.
17. Gottanka J, Johnson DH, Martus P and Lutjen-Drecoll E. Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. Journal of glaucoma. 1997; 6:123-132.
18. Lutjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp Eye Res. 2005; 81:1-4.
19. Rohen JW, Lutjen-Drecoll E, Flugel C, Meyer M and Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res. 1993; 56:683-692.
20. Schlunck G, Han H, Wecker T, Kampik D, Meyer-ter-Vehn T and Grehn F. Substrate rigidity modulates cell matrix interactions and protein expression in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2008; 49:262-269.
21. Raghunathan VK, Morgan JT, Dreier B, Reilly CM, Thomasy SM, Wood JA, Ly I, Tuyen BC, Hughbanks M, Murphy CJ and Russell P. Role of substratum stiffness in modulating genes associated with extracellular matrix and mechanotransducers YAP and TAZ. Invest Ophthalmol Vis Sci. 2013; 54:378-386.
22. Thomasy SM, Morgan JT, Wood JA, Murphy CJ and Russell P. Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells. Exp Eye Res. 2013; 113:66-73.
23. Thomasy SM, Wood JA, Kass PH, Murphy CJ and Russell P. Substratum stiffness and latrunculin B regulate matrix gene and protein expression in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2012; 53:952-958.
24. Wood JA, McKee CT, Thomasy SM, Fischer ME, Shah NM, Murphy CJ and Russell P. Substratum compliance regulates human trabecular meshwork cell behaviors and response to latrunculin B. Invest Ophthalmol Vis Sci. 2011; 52:9298-9303.
25. McKee CT, Wood JA, Shah NM, Fischer ME, Reilly CM, Murphy CJ and Russell P. The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents. Biomaterials. 2011; 32:2417-2423.
26. Haddadin RI, Oh DJ, Kang MH, Filippopoulos T, Gupta M, Hart L, Sage EH and Rhee DJ. SPARC-null mice exhibit lower intraocular pressures. Invest Ophthalmol Vis Sci. 2009; 50:3771-3777.
27. Oh DJ, Kang MH, Ooi YH, Choi KR, Sage EH and Rhee DJ. Overexpression of SPARC in human trabecular meshwork increases intraocular pressure and alters extracellular matrix. Invest Ophthalmol Vis Sci. 2013; 54:3309-3319.
28. Swaminathan SS, Oh D, Kang M, Shepard AR, Pang IH and Rhee DJ. (2014). In vivo study of the role of SPARC in TGFb2-mediated ocular hypertension. The Association for Research in Vision and Ophthalmology Annual Meeting. (Orlando, Florida.
29. Swaminathan SS, Oh DJ, Kang MH, Ren R, Jin R, Gong H and Rhee DJ. Secreted protein acidic and rich in cysteine (SPARC)-null mice exhibit more uniform outflow. Invest Ophthalmol Vis Sci. 2013; 54:2035-2047.
30. Tamm ER. Myocilin and glaucoma: facts and ideas. Prog Retin Eye Res. 2002; 21:395-428.
31. Polansky JR, Fauss DJ, Chen P, Chen H, Lutjen-Drecoll E, Johnson D, Kurtz RM, Ma ZD, Bloom E and Nguyen TD. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica. 1997; 211:126-139.
32. Wang WH, McNatt LG, Pang IH, Millar JC, Hellberg PE, Hellberg MH, Steely HT, Rubin JS, Fingert JH, Sheffield VC, Stone EM and Clark AF. Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure. J Clin Invest. 2008; 118:1056-1064.
33. Mao W, Millar JC, Wang WH, Silverman SM, Liu Y, Wordinger RJ, Rubin JS, Pang IH and Clark AF. Existence of the canonical Wnt signaling pathway in the human trabecular meshwork. Invest Ophthalmol Vis Sci. 2012.
34. Fingert JH, Stone EM, Sheffield VC and Alward WL. Myocilin glaucoma. Surv Ophthalmol. 2002; 47:547-561.
35. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013; 75:685-705.
36. Ohtani N and Hara E. Roles and mechanisms of cellular senescence in regulation of tissue homeostasis. Cancer Sci. 2013; 104:525-530.
37. Hayflick L. The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res. 1965; 37:614-636.
38. Takahashi A, Ohtani N and Hara E. Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control. Cell division. 2007; 2:10.
39. Campisi J and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007; 8:729-740.
40. Hayflick L and Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961; 25:585-621.
41. Ben-Porath I and Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest. 2004; 113:8-13.
42. von Zglinicki T, Petrie J and Kirkwood TB. Telomere-driven replicative senescence is a stress response. Nat Biotechnol. 2003; 21:229-230.
43. von Zglinicki T, Serra V, Lorenz M, Saretzki G, Lenzen-Grossimlighaus R, Gessner R, Risch A and Steinhagen-Thiessen E. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest. 2000; 80(11):1739-1747.
44. Henle ES, Han Z, Tang N, Rai P, Luo Y and Linn S. Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications. J Biol Chem. 1999; 274:962-971.
45. Serra V, von Zglinicki T, Lorenz M and Saretzki G. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem. 2003; 278:6824-6830.
46. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S and Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol. 2003; 5:741-747.
47. Chen Q, Fischer A, Reagan JD, Yan LJ and Ames BN. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A. 1995; 92:4337-4341.
48. Jeyapalan JC, Ferreira M, Sedivy JM and Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev. 2007; 128:36-44.
49. Takubo K, Aida J, Izumiyama-Shimomura N, Ishikawa N, Sawabe M, Kurabayashi R, Shiraishi H, Arai T and Nakamura K. Changes of telomere length with aging. Geriatrics & gerontology international. 2010; 10 Suppl 1:S197-206.
50. Herbig U, Ferreira M, Condel L, Carey D and Sedivy JM. Cellular senescence in aging primates. Science. 2006; 311:1257.
51. Waaijer ME, Parish WE, Strongitharm BH, van Heemst D, Slagboom PE, de Craen AJ, Sedivy JM, Westendorp RG, Gunn DA and Maier AB. The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell. 2012; 11:722-725.
52. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O and et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995; 92:9363-9367.
53. Campisi J and Sedivy J. How does proliferative homeostasis change with age? What causes it and how does it contribute to aging? J Gerontol A Biol Sci Med Sci. 2009; 64:164-166.
54. Tchkonia T, Zhu Y, van Deursen J, Campisi J and Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013; 123:966-972.
55. Liton PB, Challa P, Stinnett S, Luna C, Epstein DL and Gonzalez P. Cellular senescence in the glaucomatous outflow pathway. Exp Gerontol. 2005; 40:745-748.
56. Gotschy A, Bauer E, Schrodt C, Lykowsky G, Ye YX, Rommel E, Jakob PM, Bauer WR and Herold V. Local arterial stiffening assessed by MRI precedes atherosclerotic plaque formation. Circ Cardiovasc Imaging. 2013; 6:916-923.
57. Peloquin J, Huynh J, Williams RM and Reinhart-King CA. Indentation measurements of the subendothelial matrix in bovine carotid arteries. J Biomech. 2011; 44:815-821.
58. Tracqui P, Broisat A, Toczek J, Mesnier N, Ohayon J and Riou L. Mapping elasticity moduli of atherosclerotic plaque in situ via atomic force microscopy. J Struct Biol. 2011; 174:115-123.
59. Fisher RF. The influence of age on some ocular basement membranes. Eye (Lond). 1987; 1:184-189.
60. Spraul CW, Lang GE, Grossniklaus HE and Lang GK. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol. 1999; 44 Suppl 1:S10-32.
61. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004; 122:598-614.
62. Castle WD and Gow BS. Changes in the microindentation properties of aortic intimal surface during cholesterol feeding of rabbits. Atherosclerosis. 1983; 47:251-261.
63. Schedin P and Keely PJ. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol. 2011; 3:a003228.
64. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA and Weaver VM. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005; 8:241-254.
65. Au FW, Ghai S, Moshonov H, Kahn H, Brennan C, Dua H and Crystal P. Diagnostic performance of quantitative shear wave elastography in the evaluation of solid breast masses: determination of the most discriminatory parameter. AJR Am J Roentgenol. 2014; 203:W328-336.
66. Nishio K and Inoue A. Senescence-associated alterations of cytoskeleton: extraordinary production of vimentin that anchors cytoplasmic p53 in senescent human fibroblasts. Histochem Cell Biol. 2005; 123:263-273.
67. Nishio K, Inoue A, Qiao S, Kondo H and Mimura A. Senescence and cytoskeleton: overproduction of vimentin induces senescent-like morphology in human fibroblasts. Histochem Cell Biol. 2001; 116:321-327.
68. Garcia GG and Miller RA. Age-related defects in the cytoskeleton signaling pathways of CD4 T cells. Ageing Res Rev. 2011; 10:26-34.
69. Sanchez-Perez Y, Chirino YI, Osornio-Vargas AR, Herrera LA, Morales-Barcenas R, Lopez-Saavedra A, Gonzalez-Ramirez I, Miranda J and Garcia-Cuellar CM. Cytoplasmic p21(CIP1/WAF1), ERK1/2 activation, and cytoskeletal remodeling are associated with the senescence-like phenotype after airborne particulate matter (PM10) exposure in lung cells. Toxicol Lett. 2014; 225:12-19.
70. Chen QM, Tu VC, Catania J, Burton M, Toussaint O and Dilley T. Involvement of Rb family proteins, focal adhesion proteins and protein synthesis in senescent morphogenesis induced by hydrogen peroxide. J Cell Sci. 2000; 113:4087-4097.
71. Plodinec M, Loparic M, Suetterlin R, Herrmann H, Aebi U and Schoenenberger CA. The nanomechanical properties of rat fibroblasts are modulated by interfering with the vimentin intermediate filament system. J Struct Biol. 2011; 174:476-484.
72. Chahine NO, Blanchette C, Thomas CB, Lu J, Haudenschild D and Loots GG. Effect of age and cytoskeletal elements on the indentation-dependent mechanical properties of chondrocytes. PLoS One. 2013; 8:e61651.
73. Lee SM, Nguyen TH, Na K, Cho IJ, Woo DH, Oh JE, Lee CJ and Yoon ES. Nanomechanical measurement of astrocyte stiffness correlated with cytoskeletal maturation. J Biomed Mater Res A. 2015; 103:365-370.
74. Lulevich V, Yang HY, Isseroff RR and Liu GY. Single cell mechanics of keratinocyte cells. Ultramicroscopy. 2010; 110:1435-1442.
75. Ryder MI, Weinreb RN, Alvarado J and Polansky J. The cytoskeleton of the cultured human trabecular cell. Characterization and drug responses. Invest Ophthalmol Vis Sci. 1988; 29:251-260.
76. Iwamoto Y and Tamura M. Immunocytochemical study of intermediate filaments in cultured human trabecular cells. Invest Ophthalmol Vis Sci. 1988; 29:244-250.
77. Weinreb RN and Ryder MI. In situ localization of cytoskeletal elements in the human trabecular meshwork and cornea. Invest Ophthalmol Vis Sci. 1990; 31:1839-1847.
78. Tian B, Geiger B, Epstein DL and Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 2000; 41:619-623.
79. Clark AF, Brotchie D, Read AT, Hellberg P, English-Wright S, Pang IH, Ethier CR and Grierson I. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton. 2005; 60:83-95.
80. Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M and Howe W. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994; 35:281-294.
81. Morgan JT, Raghunathan VK, Chang YR, Murphy CJ and Russell P. Wnt inhibition induces persistent increases in intrinsic stiffness of human trabecular meshwork cells. Exp Eye Res. 2015; In Press.
82. Elzi DJ, Song M, Hakala K, Weintraub ST and Shiio Y. Wnt Antagonist SFRP1 Functions as a Secreted Mediator of Senescence. Mol Cell Biol. 2012; 32:4388-4399.
83. Cristofalo VJ and Sharf BB. Cellular senescence and DNA synthesis. Thymidine incorporation as a measure of population age in human diploid cells. Exp Cell Res. 1973; 76:419-427.
84. Yanishevsky R, Mendelsohn ML, Mayall BH and Cristofalo VJ. Proliferative capacity and DNA content of aging human diploid cells in culture: a cytophotometric and autoradiographic analysis. J Cell Physiol. 1974; 84:165-170.
85. Kumazaki T, Robetorye RS, Robetorye SC and Smith JR. Fibronectin expression increases during in vitro cellular senescence: correlation with increased cell area. Exp Cell Res. 1991; 195:13-19.
86. Angello JC, Pendergrass WR, Norwood TH and Prothero J. Proliferative potential of human fibroblasts: an inverse dependence on cell size. J Cell Physiol. 1987; 132:125-130.
87. Sherwood SW, Rush D, Ellsworth JL and Schimke RT. Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc Natl Acad Sci U S A. 1988; 85:9086-9090.
88. Kulju KS and Lehman JM. Increased p53 protein associated with aging in human diploid fibroblasts. Exp Cell Res. 1995; 217:336-345.
89. Itahana K, Campisi J and Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol. 2007; 371:21-31.
90. de Jesus BB and Blasco MA. Assessing cell and organ senescence biomarkers. Circ Res. 2012; 111:97-109.
91. Murphy KC, Morgan JT, Wood JA, Sadeli A, Murphy CJ and Russell P. The formation of cortical actin arrays in human trabecular meshwork cells in response to cytoskeletal disruption. Exp Cell Res. 2014.
92. Raghunathan VK, Morgan JT, Chang YR, Weber D, Phinney B, Murphy CJ and Russell P. Transforming growth factor beta 3 modifies mechanics and composition of extracellular matrix deposited by human trabecular meshwork cells. ACS Biomaterials Science & Engineering. 2015; In Press.
93. Kuznetsova TG, Starodubtseva MN, Yegorenkov NI, Chizhik SA and Zhdanov RI. Atomic force microscopy probing of cell elasticity. Micron. 2007; 38:824-833.
94. Cross SE, Jin YS, Tondre J, Wong R, Rao J and Gimzewski JK. AFM-based analysis of human metastatic cancer cells. Nanotechnology. 2008; 19:384003.
95. Li QS, Lee GY, Ong CN and Lim CT. AFM indentation study of breast cancer cells. Biochem Biophys Res Commun. 2008; 374:609-613.
96. Lekka M, Laidler P, Gil D, Lekki J, Stachura Z and Hrynkiewicz AZ. Elasticity of normal and cancerous human bladder cells studied by scanning force microscopy. Eur Biophys J. 1999; 28:312-316.
97. Cross SE, Jin YS, Rao J and Gimzewski JK. Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol. 2007; 2:780-783.
98. Xu W, Mezencev R, Kim B, Wang L, McDonald J and Sulchek T. Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells. PLoS One. 2012; 7:e46609.
99. Watanabe T, Kuramochi H, Takahashi A, Imai K, Katsuta N, Nakayama T, Fujiki H and Suganuma M. Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells. J Cancer Res Clin Oncol. 2012.
100. Raes M, Geuens G, de Brabander M and Remacle J. Microtubules and microfilaments in ageing hamster embryo fibroblasts in vitro. Exp Gerontol. 1983; 18:241-254.
101. Wang E and Gundersen D. Increased organization of cytoskeleton accompanying the aging of human fibroblasts in vitro. Exp Cell Res. 1984; 154:191-202.
102. Van Gansen P, Siebertz B, Capone B and Malherbe L. Relationships between cytoplasmic microtubular complex, DNA synthesis and cell morphology in mouse embryonic fibroblasts (effects of age, serum deprivation, aphidicolin, cytochalasin B and colchicine). Biol Cell. 1984; 52:161-174.
103. Raes M. Involvement of microtubules in modifications associated with cellular aging. Mutat Res. 1991; 256:149-168.
104. Pesen D and Hoh JH. Micromechanical architecture of the endothelial cell cortex. Biophys J. 2005; 88:670-679.
105. Haga H, Sasaki S, Kawabata K, Ito E, Ushiki T and Sambongi T. Elasticity mapping of living fibroblasts by AFM and immunofluorescence observation of the cytoskeleton. Ultramicroscopy. 2000; 82:253-258.
106. Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL and Lee RT. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest. 2004; 113:370-378.
107. Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG and Lee RT. Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem. 2006; 281:25768-25780.
108. Lee JS, Hale CM, Panorchan P, Khatau SB, George JP, Tseng Y, Stewart CL, Hodzic D and Wirtz D. Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migration. Biophys J. 2007; 93:2542-2552.
109. Stewart-Hutchinson PJ, Hale CM, Wirtz D and Hodzic D. Structural requirements for the assembly of LINC complexes and their function in cellular mechanical stiffness. Exp Cell Res. 2008; 314:1892-1905.
110. Maniotis AJ, Chen CS and Ingber DE. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci U S A. 1997; 94:849-854.
111. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003; 423:293-298.
112. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M and Levy N. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003; 300:2055.
113. Verstraeten VL, Ji JY, Cummings KS, Lee RT and Lammerding J. Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors. Aging Cell. 2008; 7:383-393.
114. Dahl KN, Scaffidi P, Islam MF, Yodh AG, Wilson KL and Misteli T. Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2006; 103:10271-10276.
115. Snow CJ, Dar A, Dutta A, Kehlenbach RH and Paschal BM. Defective nuclear import of Tpr in Progeria reflects the Ran sensitivity of large cargo transport. J Cell Biol. 2013; 201:541-557.
116. Kelley JB, Datta S, Snow CJ, Chatterjee M, Ni L, Spencer A, Yang CS, Cubenas-Potts C, Matunis MJ and Paschal BM. The defective nuclear lamina in Hutchinson-Gilford progeria syndrome disrupts the nucleocytoplasmic Ran gradient and inhibits nuclear localization of Ubc9. Mol Cell Biol. 2011; 31:3378-3395.
117. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R and Collins FS. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2004; 101:8963-8968.
118. Cao K, Capell BC, Erdos MR, Djabali K and Collins FS. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Proc Natl Acad Sci U S A. 2007; 104:4949-4954.
119. Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD and Collins FS. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2005; 102:12879-12884.
120. Glynn MW and Glover TW. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet. 2005; 14:2959-2969.
121. Cao K, Blair CD, Faddah DA, Kieckhaefer JE, Olive M, Erdos MR, Nabel EG and Collins FS. Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. J Clin Invest. 2011; 121:2833-2844.
122. Scaffidi P and Misteli T. Lamin A-dependent nuclear defects in human aging. Science. 2006; 312:1059-1063.
123. Rodriguez S, Coppede F, Sagelius H and Eriksson M. Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging. Eur J Hum Genet. 2009; 17:928-937.
124. Satoh W, Matsuyama M, Takemura H, Aizawa S and Shimono A. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis. 2008; 46:92-103.
125. Kawano Y and Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 2003; 116:2627-2634.
126. Yu J and Virshup DM. Updating the Wnt pathways. Biosci Rep. 2014.
127. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127:469-480.
128. Freese JL, Pino D and Pleasure SJ. Wnt signaling in development and disease. Neurobiol Dis. 2010; 38:148-153.
129. Macdonald BT and He X. Frizzled and LRP5/6 Receptors for Wnt/beta-Catenin Signaling. Cold Spring Harb Perspect Biol. 2012; 4.
130. Wordinger RJ, Sharma T and Clark AF. The Role of TGF-beta2 and Bone Morphogenetic Proteins in the Trabecular Meshwork and Glaucoma. J Ocul Pharmacol Ther. 2014; 30:154-162.
131. Rhee DJ, Haddadin RI, Kang MH and Oh DJ. Matricellular proteins in the trabecular meshwork. Exp Eye Res. 2009; 88:694-703.
132. Tamm ER and Fuchshofer R. What increases outflow resistance in primary open-angle glaucoma? Surv Ophthalmol. 2007; 52 Suppl 2:S101-104.
133. Fuchshofer R and Tamm ER. Modulation of extracellular matrix turnover in the trabecular meshwork. Exp Eye Res. 2009; 88:683-688.
134. Sacca SC and Izzotti A. Focus on molecular events in the anterior chamber leading to glaucoma. Cell Mol Life Sci. 2013.
135. Ghanem AA, Arafa LF and El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr Eye Res. 2010; 35:295-301.
136. Izzotti A, Sacca SC, Longobardi M and Cartiglia C. Mitochondrial damage in the trabecular meshwork of patients with glaucoma. Arch Ophthalmol. 2010; 128:724-730.
137. Sacca SC and Izzotti A. Oxidative stress and glaucoma: injury in the anterior segment of the eye. Prog Brain Res. 2008; 173:385-407.
138. Sacca SC, Izzotti A, Rossi P and Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp Eye Res. 2007; 84:389-399.
139. Sacca SC, Pascotto A, Camicione P, Capris P and Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol. 2005; 123:458-463.
140. Alvarado J, Murphy C and Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology. 1984; 91:564-579.
141. Alvarado J, Murphy C, Polansky J and Juster R. Age-related changes in trabecular meshwork cellularity. Invest Ophthalmol Vis Sci. 1981; 21:714-727.
142. Grierson I and Howes RC. Age-related depletion of the cell population in the human trabecular meshwork. Eye. 1987; 1:204-210.
143. Morgan JT, Wood JA, Walker NJ, Raghunathan VK, Borjesson DL, Murphy CJ and Russell P. Human Trabecular Meshwork Cells Exhibit Several Characteristics of, but Are Distinct from, Adipose-Derived Mesenchymal Stem Cells. J Ocul Pharmacol Ther. 2014; 30:254-266.
144. Yamazaki Y, Matsunaga H, Nishikawa M, Ando A, Kaneko S, Okuda K, Wada M, Ito S and Matsumura M. Senescence in cultured trabecular meshwork cells. Br J Ophthalmol. 2007; 91:808-811.
145. Mahaffy RE, Shih CK, MacKintosh FC and Kas J. Scanning probe-based frequency-dependent microrheology of polymer gels and biological cells. Phys Rev Lett. 2000; 85:880-883.
146. Dimitriadis EK, Horkay F, Maresca J, Kachar B and Chadwick RS. Determination of elastic moduli of thin layers of soft material using the atomic force microscope. Biophys J. 2002; 82:2798-2810.
147. Ahearne M, Yang Y, El Haj AJ, Then KY and Liu KK. Characterizing the viscoelastic properties of thin hydrogel-based constructs for tissue engineering applications. Journal of the Royal Society, Interface/the Royal Society. 2005; 2:455-463.
148. Vinckier A and Semenza G. Measuring elasticity of biological materials by atomic force microscopy. FEBS Lett. 1998; 430:12-16.
149. Anseth KS, Bowman CN and Brannon-Peppas L. Mechanical properties of hydrogels and their experimental determination. Biomaterials. 1996; 17:1647-1657.